CAPITAL STOCK [Text Block] | 7. CAPITAL STOCK (a) Common stock During the three months ended March 31, 2016, no common stock was issued. (b) Preferred stock During the period ended March 31, 2016, the Company designated 19,000,100 shares of Series A preferred stock with a par value of $0.001 per share. Each share of preferred stock was convertible into one common share at any time at the holder’s option, at a conversion of $0.12 per share subject to the adjustments to the conversion ratio. The adjustment to the conversion price of these preferred shares is based on the lowest of the share price of any common shares issued, the exercise price of any options granted or re-priced, or any preferred shares issued after the issuance of these preferred shares. The preferred stock was unlisted, non-retractable and non-redeemable. The preferred stockholders were entitled to the number of votes equal to the number of whole shares of common stock into which the preferred stock are convertible. The preferred stockholders were further entitled to the same dividends and distributions as the common stockholders. In connection with the issuance of the Convertible Note (Note 6) 100 shares of Series A Preferred Stock, $0.001 par value, were issued to the note holder. (c) Stock options The Company has a stock option plan, adopted in 2005, and a stock option/stock issuance plan, adopted in 2010, which has been replaced by a stock incentive plan adopted in June 2015 (individually, the “2005 Plan”, the “2010 Plan”, and the “2015 Plan”, respectively, and, collectively, the “Plans”). Under the Plans, the Company is authorized to grant options to executive officers and directors, employees and consultants of the Company. The 2005 Plan was originally authorized to grant 3,140,000 shares, and the 2015 Plan was originally authorized to issue 4,641,040 shares, which amount is increased at the end of each year to represent 10% of the total number of shares of Common Stock outstanding on the last trading day in December of the immediately preceding calendar year, less 3,949,500 shares. Effective January 1, 2016, the 2015 Plan authorized shares automatically increased to 5,661,944 shares. The terms of any stock options granted under the 2005 Plan may not exceed five years and the exercise price of any stock option granted may not be discounted below the maximum discount permitted under the policies of the Toronto Stock Exchange. The terms of any stock options granted under the 2015 Plan may not exceed ten years and the exercise price of any stock option plan is fixed by the plan administrator. The Company originally also adopted a management compensation pool for the benefit of officers, directors and employees of the Company. The pool consists of 1% of the outstanding shares at the end of each year. The shares granted under the compensation pool program are issued under the 2015 Plan. The following table represents service-based stock option activity during the three months ended March 31, 2016 and the year ended December 31, 2015: March 31, 2016 December 31, 2015 Number of Weighted Average Number of Weighted Average Shares Exercise Price Shares Exercise Price Outstanding - beginning of period 1,375,000 $ 0.45 1,225,000 $ 0.55 Granted - $ - 300,000 $ 0.45 Expired /Cancelled - $ - (150,000 ) $ - Outstanding and exercisable – end of period 1,375,000 $ 0.45 1,375,000 $ 0.45 As at March 31, 2016 and December 31, 2015, the following stock options were outstanding: Exercise March 31, December 31, Expiry Date Price 2016 2015 October 2, 2017 $ 0.45 375,000 375,000 December 31, 2017 $ 0.45 1,000,000 1,000,000 1,375,000 1,375,000 The shares under option at March 31, 2016 had an intrinsic value of $nil (December 31, 2015 - $nil) and a weighted average remaining contractual life of 1.75 (December 31, 2015 - 3) years. (d) Stock-based compensation During the three months ended March 31, 2016, $8,972 (2015 - $48,919) was recognized as stock-based compensation for amortization of shares of common stock issuable upon the market performance of the Company’s stock. The remaining unamortized balance of $120,036 (2015 - $129,008) will be amortized through July 2019. (e) Warrants On March 16, 2016, the Company issued warrants to purchase 8,333,333 shares of Common Stock, in connection with the Convertible Note ( Note 6 Stock purchase warrant activity for the period ended March 31, 2016 and the year ended December 31, 2015 is as follows: March 31, 2016 December 31, 2015 Weighted Weighted Number Average Number Average of Warrants Exercise Price of Warrants Exercise Price Outstanding - beginning of year 35,362,585 $ 0.34 21,487,585 $ 0.55 Issued 8,333,333 0.30 13,875,000 0.35 Outstanding - end of year 43,695,918 $ 0.33 35,362,585 $ 0.34 As at March 31, 2016 and December 31, 2015, the following warrants were outstanding: March 16, December 31, Expiry Date Exercise Price 2016 2015 April 30, 2016 $ 0.30 1,770,328 1,770,328 April 30, 2016 $ 0.30 910,534 910,534 April 30, 2016 $ 0.30 2,367,437 2,367,437 December 31, 2017 $ 0.30 5,714,286 5,714,286 December 31, 2017 $ 0.65 600,000 600,000 December 31, 2018 $ 0.35 4,500,000 4,500,000 December 31, 2018 $ 0.35 5,625,000 5,625,000 December 31, 2018 $ 0.35 13,875,000 13,875,000 March 16, 2019 $ 0.30 8,333,333 - 43,695,918 35,362,585 |